81 results
10-Q/A
2013 Q2
PCSA
Processa Pharmaceuticals Inc
6 Sep 13
Quarterly report (amended)
12:00am
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
13 Feb 20
Processa Pharmaceuticals Appoints
9:30am
in a short amount of time and I look forward to working alongside my fellow Board members and company management as we continue to build long term shareholder
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
to spend more time focusing on our long-term strategic direction and our pipeline,” said Dr. David Young, CEO and Chairman of Processa. “Mike
8-K
EX-99.1
l2nggvb9w2lmc
25 Feb 20
Processa Pharmaceuticals Provides Shareholder Update
9:30am
8-K
EX-99.1
m9nrqng
8 Aug 23
Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
10:30am
8-K
EX-99.1
uzky2s7g8mj ls
12 Oct 17
Entry into a Material Definitive Agreement
12:00am
10-Q/A
rhif094
6 Sep 13
Quarterly report (amended)
12:00am
DEF 14A
89z7jxt31
26 Apr 19
Definitive proxy
5:02pm